Market Challenges And Opportunities
Global Chemotherapy Devices Market – Drivers
- Increasing prevalence of cancer: Increasing prevalence of cancer is expected to propel growth of the global chemotherapy devices market over the forecast period. For instance, in February 2022, according to data provided by World Health Organization (WHO), cancer is a leading cause of death worldwidethat accounted for nearly 10 Mn deaths in 2020, or nearly one in every six deaths. The most common cancers are breast, lung, colon and rectum, and prostate cancers. The most common in 2020 (in terms of new cases of cancer) were breast (2.26 Mn cases); lung cancer (2.21 Mn cases); colon and rectum (1.93 Mn cases); prostate (1.41 Mn cases)
- Increasing geriatric population: Increasing geriatric population is expected to drive the global chemotherapy devices market growth over the forecast period. For instance, in October 2022, according to data provided by World Health Organization (WHO), in 2020, Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. The share of the population aged 60 years and over will increase from 1 Mn in 2020 to 1.4 Mn. By 2050, the world’s populations of people aged 60 years and older will double (2.1 Mn ). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 Mn .
Global Chemotherapy Devices Market: Restraint
- Side Effects Associated with Chemotherapy: The factors such as high cost of chemotherapy devices and side effects associated with chemotherapy are expected to hamper growth of the global chemotherapy devices market over the forecast period. For instance, in May 2020, according to data provided by American Cancer Society, various common side effects caused by chemotherapy includes fatigue, hair loss, easy bruising and bleeding, infection, anemia (low red blood cell counts), nausea and vomiting, appetite changes, constipation, diarrhea, mouth, tongue, and throat problems such as sores and pain with swallowing and among others.
- Counterbalance: The key market players are focused on maintaining quality of products to reduced the side effects of the products.
Restraints & Challenges: |
- High cost of chemotherapy devices
- Side effects associated with chemotherapy
|